Editor-in-Chief
Tarek Magdy Mohamed
Northwestern University, Department of Pharmacology and center of pharmacogenomics · United States
Editorial leadership for International Journal of Personalized Medicine
Research interests
- Personalized Medicine
- Pharmacogenomics
- Human Induced Stem Cells
- Chemotherapy-Induced Cardiotoxicity
- And Cardiovascular Diseases
Biography
- Bachelor of Pharmaceutical sciences, Alexandria University, Egypt
- Masters in Biochemistry, Stockholm University, Sweden
- Ph.D. in clinical pharmacology and Pharmacogenomics, Tubingen University, Tubingen, Germany
- Postdoctoral fellow, Northwestern University, Chicago, USA
Selected publications
- Identification of Drug Transporter Genomic Variants and Inhibitors That Protect Against Doxorubicin-Induced Cardiotoxicity 2022 cited 90×
- Interactions between integrin α9β1 and VCAM-1 promote neutrophil hyperactivation and mediate poststroke DVT 2024 cited 14×
- Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy – A COG‐ALTE03N1 Report 2023 cited 10×
- Use of Hipsc to Explicate Genomic Predisposition to AnthrAcycline-Induced Cardiotoxicity 2021 cited 7×
- Neutrophil CD14 is a driver and a therapeutic target for deep vein thrombosis Recent 2026 cited 2×
- A Novel Transcription Factor Combination for Direct Reprogramming to a Spontaneously Contracting Human Cardiomyocyte-like State 2023 cited 1×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJPM for your work?
This journal is guided by Tarek Magdy Mohamed (Northwestern University, Department of Pharmacology and center of pharmacogenomics) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.